Dyadic International (DYAI) to Release Quarterly Earnings on Wednesday

Dyadic International (NASDAQ:DYAI) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, March 26th. Analysts expect the company to announce earnings of ($0.04) per share and revenue of $1.60 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Dyadic International Price Performance

Shares of DYAI opened at $1.41 on Monday. The firm has a market capitalization of $41.72 million, a PE ratio of -6.13 and a beta of 0.95. The company’s 50-day moving average is $1.49 and its 200-day moving average is $1.42. Dyadic International has a fifty-two week low of $0.93 and a fifty-two week high of $2.67. The company has a debt-to-equity ratio of 1.54, a current ratio of 5.15 and a quick ratio of 5.15.

Institutional Investors Weigh In On Dyadic International

A hedge fund recently raised its stake in Dyadic International stock. Bank of America Corp DE grew its stake in Dyadic International, Inc. (NASDAQ:DYAI) by 16,146.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,132 shares of the biotechnology company’s stock after purchasing an additional 26,965 shares during the period. Bank of America Corp DE owned about 0.09% of Dyadic International worth $47,000 as of its most recent filing with the Securities and Exchange Commission. 27.95% of the stock is owned by institutional investors.

About Dyadic International

Dyadic International, Inc, a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health.